Enhanced ADCC and NK Cell Activation of an Anticarcinoma Bispecific Antibody by Genetic Insertion of a Modified IL-15 Cross-linker
about
CD133, Selectively Targeting the Root of CancerBispecific Antibodies as a Development Platform for New Concepts and Treatment Strategies.Harnessing NK Cell Memory for Cancer Immunotherapy.Antibody-dependent cell cytotoxicity: immunotherapy strategies enhancing effector NK cells.Tetraspecific scFv construct provides NK cell mediated ADCC and self-sustaining stimuli via insertion of IL-15 as a cross-linker.Recombinant Antibodies to Arm Cytotoxic Lymphocytes in Cancer Immunotherapy.TriKEs and BiKEs join CARs on the cancer immunotherapy highway.Leveraging natural killer cells for cancer immunotherapy.Effects of a Phosphoinositide-3-Kinase Inhibitor on Anaplastic Thyroid Cancer Stem CellsDevelopment of a Deimmunized Bispecific Immunotoxin dDT2219 against B-Cell Malignancies.Natural Killer Cell-Based Immunotherapy in Gynecologic Malignancy: A Review.Engineering of Anti-CD133 Trispecific Molecule Capable of Inducing NK Expansion and Driving Antibody-Dependent Cell-Mediated Cytotoxicity.Tumor immunotherapy: New aspects of natural killer cells.Bi-specific and tri-specific antibodies- the next big thing in solid tumor therapeutics
P2860
Q28066353-A3A55C7E-892E-484B-8C8B-94959E7AB49CQ34548319-BCEFF16D-5482-4DE3-9B8C-07D0378B817DQ38988913-9B9119E7-8145-45A4-9857-EFC1C1EFD024Q39110347-4E011223-A554-460A-AAC6-78BEABA3D3ADQ42221543-6A74240F-B37D-495D-B7ED-9A1235A327BBQ42660142-D3D20C14-8AEA-498A-82E4-0D9F4C2F7841Q42801713-046EDDA1-7650-450D-938D-92CA56B1A01FQ43865719-A1534D9C-3A23-48F6-BB0E-C3C1702280DFQ47107349-369D05E7-5D9D-492B-AE42-CA7C0BAA5550Q49540233-69A974E0-620D-43E9-961C-E3BE46694541Q49724715-77221FF4-612C-4C9B-B291-CDFFA49B9D31Q50992976-B63FB232-D723-4B3C-A93A-B751B7C0318FQ55107050-1C7C7EAF-7F79-4009-8B17-EF38E726054DQ57151874-E11B8F70-6E7F-4F2C-BDB0-22720BAE2E30
P2860
Enhanced ADCC and NK Cell Activation of an Anticarcinoma Bispecific Antibody by Genetic Insertion of a Modified IL-15 Cross-linker
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Enhanced ADCC and NK Cell Acti ...... a Modified IL-15 Cross-linker
@en
type
label
Enhanced ADCC and NK Cell Acti ...... a Modified IL-15 Cross-linker
@en
prefLabel
Enhanced ADCC and NK Cell Acti ...... a Modified IL-15 Cross-linker
@en
P2093
P2860
P356
P1433
P1476
Enhanced ADCC and NK Cell Acti ...... a Modified IL-15 Cross-linker
@en
P2093
Daniel A Vallera
Elizabeth Taras
Jeff S Miller
Joerg U Schmohl
Martin Felices
P2860
P304
P356
10.1038/MT.2016.88
P577
2016-05-09T00:00:00Z